Intelligence / Healthtech / New Clinical Trials / Arjil Pharmaceuticals LLC
Clinicaltrial registered3 Nov 2026
Arjil Pharmaceuticals LLC
3 Nov 2026: Trial registered · A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 3 Nov 2026
- Title
- A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis
- Conditions
- Dermatitis Atopic
- Phase
- Phase 2
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Taiwan
- Country
- Taiwan
- Reference
- NCT07914088
- Location
- Taiwan
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Arjil Pharmaceuticals LLC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Taiwan
New Clinical Trials
12 NovNovo Nordisk A/Strial registered · A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical29 OctElixiron Immunotherapeutics Inc.trial registered · A Phase 1, Open-Label, Two-Stage, Food Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of EI-1071 Under Fasted or Fed Conditions in Healthy VolunteersClinical27 OctT-MAXIMUM Pharmaceutical Inctrial registered · The METAMAX Study: MT027 Allogeneic CAR-T for Brain Metastases From Advanced Solid TumorsClinical22 OctBionime Corporationtrial registered · RIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes MellitusClinical22 OctDaiichi Sankyotrial registered · A Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]Clinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.